Charles W Stiefel insider trades: Barrier Therapeutics (BTRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Charles reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 6, 2008 | BTRX | ↑ Buy | 1,033,464 | $4.15 | $4.3M | Direct | Aug 6, 2008 (0d) |
| Aug 5, 2008 | BTRX | ↑ Buy | 34,266,494 | $4.15 | $142.2M | See note | Aug 5, 2008 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Charles W Stiefel's insider trades
Charles W Stiefel is an insider at Barrier Therapeutics (BTRX). Since Aug 5, 2008, Charles has reported 2 open-market purchases worth $146.5M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BTRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.